Section Arrow
CODX.NASDAQ
- Co-Diagnostics
(Financial Status)
Quotes are at least 15-min delayed:2025/02/01 11:59 EST
Last
 0.751
-0.039 (-4.94%)
Day High 
0.795624 
Prev. Close
0.79 
1-M High
1.07 
Volume 
224.28K 
Bid
0.727
Ask
0.81
Day Low
0.7209 
Open
0.795624 
1-M Low
0.688 
Market Cap 
25.22M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.8 
20-SMA 0.8 
50-SMA 0.84 
52-W High 2.2299 
52-W Low 0.67 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.38/-1.17
Enterprise Value
27.38M
Balance Sheet
Book Value Per Share
2.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.81M
Operating Revenue Per Share
0.23
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.9608-0.1292-11.85%-- 
QSIQuantum-Si1.98+0.02+1.02%-- 
PACBPacific Biosciences of California1.54-0.06-3.75%-- 
MDTMedtronic plc90.82-1.17-1.27%28.13PE
ABTAbbott Laboratories127.93-0.88-0.68%39.2PE
Quotes are at least 15-min delayed:2025/02/01 11:59 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.